6-fluoro-18[F]-L-DOPA - Advanced Accelerator Applications

Drug Profile

6-fluoro-18[F]-L-DOPA - Advanced Accelerator Applications

Alternative Names: DOPAVIEW

Latest Information Update: 21 Jan 2017

Price : $50

At a glance

  • Originator Advanced Accelerator Applications
  • Class Diagnostic agents; Imaging agents
  • Mechanism of Action Positron-emission tomography enhancers
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Registered Parkinson's disease

Most Recent Events

No Data Available
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top